piper methysticum extract
extract of the leaves, roots and stems of the kawa-kawa, piper methysticum, piperaceae
Identification
| Name | piper methysticum extract |
| IUPAC | piper methysticum extract |
| CAS Number | 84696-40-2 |
| FDA UNII | Search |
Regulatory
Physical Properties
| Food Chemicals Codex Listed | No |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | skin conditioning |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | cosmetic agents |
| Recommendation for piper methysticum extract usage levels up to | not for fragrance use. |
| Recommendation for piper methysticum extract flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
extract of the leaves, roots and stems of the kawa-kawa, piper methysticum, piperaceae
kava-kava extract
kawa extract
PubMed:
Fatal kavalactone intoxication by suicidal intravenous injection.
PubMed:
Flavokawains B and C, melanogenesis inhibitors, isolated from the root of Piper methysticum and synthesis of analogs.
PubMed:
Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster).
PubMed:
Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.
PubMed:
Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
PubMed:
Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study.
PubMed:
Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
PubMed:
[Medicinal plants for the treatment of generalized anxiety disorder: a review of controlled clinical studies].
PubMed:
Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?
PubMed:
Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
PubMed:
Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappaB and MAPK signaling pathways.
PubMed:
Kava hepatotoxicity: pathogenetic aspects and prospective considerations.
PubMed:
Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
PubMed:
Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
PubMed:
The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.
PubMed:
Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
PubMed:
Discriminative-stimulus and time-course effects of kava-kava (Piper methysticum) in rats.
PubMed:
Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots.
PubMed:
Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.
PubMed:
Identification of C-glycoside flavonoids as potential mutagenic compounds in kava.
PubMed:
Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract.
PubMed:
Safety of ethanolic kava extract: Results of a study of chronic toxicity in rats.
PubMed:
Melanogenesis stimulation in murine B16 melanoma cells by Kava (Piper methysticum) rhizome extract and kavalactones.
PubMed:
Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
PubMed:
HPLC analysis of flavokavins and kavapyrones from Piper methysticum Forst.
PubMed:
Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
PubMed:
Determination of six kavalactones in dietary supplements and selected functional foods containing Piper methysticum by isocratic liquid chromatography with internal standard.
PubMed:
Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
PubMed:
Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes.
PubMed:
Enhanced cognitive performance and cheerful mood by standardized extracts of Piper methysticum (Kava-kava).
PubMed:
Kava does not display metabolic toxicity in a homogeneous cellular assay.
PubMed:
Saccade and cognitive impairment associated with kava intoxication.
PubMed:
Quantitative elimination of Flavokavines A and B from Kava Kava (Piper methysticum G. Forst) by isoelectric focused adsorptive bubble separation.
PubMed:
Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice.
PubMed:
Isolation and synthesis of TNF-alpha release inhibitors from Fijian kawa (Piper methysticum).
PubMed:
Identification of novel electrophilic metabolites of piper methysticum Forst (Kava).
PubMed:
Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.
PubMed:
Kava-Kava administration reduces anxiety in perimenopausal women.
PubMed:
Saccade and cognitive function in chronic kava users.
PubMed:
Kava extract for treating anxiety.
PubMed:
Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).
PubMed:
Anxiolytic-like effects of kava-kava in the elevated plus maze test--a comparison with diazepam.
PubMed:
Densitometric analysis of kawain in kava-kava root extracts.
PubMed:
Kava extract for treating anxiety.
PubMed:
A systematic review of the safety of kava extract in the treatment of anxiety.
PubMed:
Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots.
PubMed:
Novel compounds from Piper methysticum Forst (Kava Kava) roots and their effect on cyclooxygenase enzyme.
PubMed:
Synergy and other interactions in phytomedicines.
PubMed:
Kava extract for treating anxiety.
PubMed:
Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers--a review.
PubMed:
Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm.
PubMed:
Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.
PubMed:
Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
PubMed:
[Kava-kava preparations--alternative anxiolytics].
PubMed:
Electrospray high performance liquid chromatography-mass spectrometry in phytochemical analysis of kava (Piper methysticum) extract.
PubMed:
Efficacy of a special Kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin - A double-blind placebo-controlled study of four weeks treatment.
PubMed:
Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain.
PubMed:
Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task.
PubMed:
Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents.
PubMed:
Effect of aqueous and lipid-soluble extracts of kava on the conditioned avoidance response in rats.
PubMed:
Comparison of the central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum).